Related Experiment Video
Updated: Jul 2, 2025

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
New 1H-1,2,4-Triazolyl Derivatives as Antimicrobial Agents
Natalia Sucman1, Eugenia Stingaci1, Lucian Lupascu1
1Laboratory of Organic Synthesis, Moldova State University, 3 str. Academiei, Chisinau, MD-2028, Moldova.
New triazolyl derivatives show potent antimicrobial activity against bacteria and fungi, outperforming standard drugs. Docking studies suggest inhibition of MurB and CYP51 enzymes, with compounds adhering to Lipinski
Area of Science:
- Medicinal Chemistry
- Antimicrobial Drug Discovery
- Computational Chemistry
Background:
- The rise of antimicrobial resistance necessitates the development of novel therapeutic agents.
- 1H-1,2,4-triazolyl derivatives represent a promising class of compounds with potential biological activities.
- In silico methods like molecular docking can guide the selection of compounds for experimental validation.
Purpose of the Study:
- To synthesize and evaluate the antimicrobial efficacy of novel 1H-1,2,4-triazolyl derivatives.
- To compare the activity of synthesized compounds against bacterial and fungal strains with existing drugs.
- To elucidate the potential molecular mechanisms underlying the observed antimicrobial effects.
Main Methods:
- Synthesis of new 1H-1,2,4-triazolyl derivatives.
- Antimicrobial activity testing against five bacterial and eight fungal strains using Minimum Inhibitory Concentration (MIC).
- Molecular docking studies to predict enzyme inhibition targets (MurB for bacteria, CYP51 for fungi).
- Assessment of drug-likeness using Lipinski's rule of five.
Main Results:
- All synthesized compounds exhibited antibacterial activity, surpassing ampicillin and chloramphenicol in potency.
- Compounds demonstrated significantly higher antifungal activity (6-45 times) compared to ketoconazole and bifonazole.
- Compound 4a showed the best antifungal activity, while specific compounds displayed high sensitivity against certain fungal and bacterial strains.
- Molecular docking suggested inhibition of E. coli MurB for antibacterial action and C. albicans CYP51 for antifungal action.
- All tested compounds complied with Lipinski's rule of five, indicating favorable pharmacokinetic properties.
Conclusions:
- Novel 1H-1,2,4-triazolyl derivatives possess significant broad-spectrum antimicrobial properties.
- These compounds represent potential lead candidates for developing new antibacterial and antifungal agents.
- The identified molecular targets (MurB and CYP51) provide a basis for further mechanistic studies and drug design.
Related Concept Videos
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Diazonium Group Substitution: –OH and –H
Antihypertensive Drugs: Thiazide-Class Diuretics
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
Combined Effects of Drugs: Synergism
Such synergistic combinations...

